Excess Reinsurance
Expanded protection for Blue partners that reduces risk exposure, increases actuarial credibility, and generates unmatched collective buying power through economies of scale
Protect your balance sheet from large claims with BCS RiskNavigator
Excess of Loss
Protection against disruption caused by large, unpredictable high-cost medical claims while leveraging the scale of BCBS companies
PreserveRx
Holistic clinical and financial solution specifically designed to manage high-cost gene therapies
Risk Management
Access to a variety of value-added services, along with insights from national partners to help manager your exposure to high-cost claims
Did you know?
BCS recently acquired Medical Risk Managers to expand its RiskNavigator solution set. Learn more.
Gene Therapy Update: Roctavian Sees Slight Delay
Last week BioMarin announced a slight delay in the next steps of FDA evaluation of their gene therapy treatment for hemophilia A, Roctavian. Roctavian (previously referred to as Valrox) is the gene therapy for hemophilia A that has been in…